{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-24-000103","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.903762+00:00","generated_at":"2026-05-31T10:20:54.394128+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Pacira's EXPAREL patent invalidated by New Jersey court; company plans appeal","bullets":["U.S. District Court for D.N.J. ruled Pacira's U.S. Patent No. 11,033,495 for EXPAREL is invalid.","Company intends to appeal the decision to the U.S. Court of Appeals for the Federal Circuit.","Three separate infringement suits against eVenus remain ongoing; additional patents pending.","CEO Frank D. Lee stated belief in patent strength and that EXPAREL franchise is well protected."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-24-000103","json":"https://secwatch.observer/filing/0001396814-24-000103.json","markdown":"https://secwatch.observer/filing/0001396814-24-000103.md","text":"https://secwatch.observer/filing/0001396814-24-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000103/0001396814-24-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000103/pcrx-20240809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:20:54.394128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}